Latest news

Posts by eXoZymes

Invizyne Technologies Announces Pricing of $15 Million Initial Public Offering

With NREL's Help, GCxN Company Readies for Initial Public Offering

NREL

NREL (DoE) working with Invizyne in their 'Advancing Clean Tech to Energize the Future' project - a fireside chat

Commercializing Invizyne’s cell-free platform - fireside chat with Zachary Karl, PhD, VP of BizDev - and - Lou Basenese

Invizyne IPO: interview with Dr. James J. Lalonde by MDB Capital President and Chief Market Strategist Lou Basenese

MDB Capital Announces Record Date and Expected Timing for Initial Public Offering for Invizyne Technologies

CEO Michael Heltzen and Co-Founder & VP of Research Dr. Tyler Korman present the Invizyne story and IPO opportunity to investors

MDB Capital CEO and Invizyne board member, Chris Marlett, presents the Invizyne story and initial public offering (IPO) opportunity to investors via Zoom on June 11, 2024

The story of eXoZymes: Interview with Tyler Korman and Paul Opgenorth

Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq